FRM
BIOA

Fox Run Management’s BioAge Labs BIOA Stock Holding History

Fox Run Management’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$172K Sell
10,850
-7,184
-40% -$138K 0.03% 783
2025
Q4 		$239K Buy
+18,034
New +$160K 0.04% 756

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Fox Run Management's BIOA Position: Q1 2026 in Review

Fox Run Management reduced its BioAge Labs (BIOA) stake by 40% in Q1 2026, selling an estimated $138K and leaving 10,850 shares worth $172K. The position accounts for 0.03% of the portfolio, ranked #783.

Fox Run Management first reported a position in BIOA in Q4 2025 and has held it in 2 quarters since. The position peaked at $239K in Q4 2025. 144 funds tracked by Wall St. Rank hold BIOA as of Q1 2026.

  • Fox Run Management held 10,850 shares of BioAge Labs worth $172K as of Q1 2026.
  • Fox Run Management sold 7,184 BioAge Labs shares in Q1 2026, an estimated $138K.
  • BioAge Labs made up 0.03% of Fox Run Management's portfolio in Q1 2026, its #783 holding.
  • Fox Run Management first reported a position in BioAge Labs in Q4 2025 and has held it in 2 quarters since.
  • Fox Run Management's BioAge Labs position peaked at $239K in Q4 2025.
  • 144 funds tracked by Wall St. Rank held BioAge Labs as of Q1 2026.

Based on Fox Run Management's 13F filing for Q1 2026, filed 12 May 2026.